Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 3 of the 17 sources its claims cite were checked for support.
Abstract
Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized ≈16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
Overview
CoChat Summary
TL;DR
This study developed a method to isolate microgram quantities of drusen and analyzed their proteome by LC MS/MS, identifying 129 proteins from normal and AMD donor eyes. It reports oxidative protein modifications, especially carboxyethyl pyrrole adducts, that are more abundant in AMD Bruch’s membrane, supporting a role for oxidative injury in AMD pathogenesis.
Key findings
- LC MS/MS of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins: 107 from normal donors and 62 from AMD donors. About 38% (41/107) of normal-donor proteins were also found in AMD donors, and 65% (42/62) of AMD-donor proteins were found in normal donors; 21 of 62 AMD proteins (≈33%) were not observed in normal donor drusen.
- TIMP3, clusterin, vitronectin, and serum albumin were the most common proteins in normal donor drusen, detectable in up to 80% of tissues from the 18 normal donors and 60% of drusen preparations from the five AMD donors. Crystallin was detected more frequently in AMD donor drusen.
- Immunocytochemistry localized ≈16% (21/129) of identified proteins in drusen.
- Oxidative modifications were observed, including apparent crosslinked species of TIMP3 and vitronectin and carboxyethyl pyrrole (CEP) protein adducts. By Western analysis, CEP immunoreactivity was present in 9 of 11 AMD samples versus 2 of 11 age-matched controls (Fischer’s test, P = 0.004 single-sided); carboxymethyl lysine was also detected in drusen.
Methods
- Human donor eyes from 29 normal and 16 AMD donors, ages 56–98 years, were used. Drusen isolation and protein identification used 23 eyes (18 normal, five AMD); Western analyses used 22 eyes (11 normal, 11 AMD). Eyes were enucleated 1.5–7 h after death and frozen.
- Drusen were manually isolated from Bruch’s membrane, proteins were extracted, trypsin-digested, and analyzed by liquid chromatography tandem MS (LC MS/MS) with database searching. Immunocytochemistry and Western analysis were used to confirm drusen localization and detect oxidative modifications.
- For CEP Western analysis, Bruch’s membrane/RPE/choroid from AMD and age- and gender-matched normal donors was subjected to SDS/PAGE (≈20 µg protein per lane) and probed with anti-CEP antibodies.
Limitations
- The paper states that mass spectrometric analyses did not measure protein abundance; the number of proteins identified per drusen preparation varied from 0 to 39 and averaged 19. It also notes that some identified proteins may be soluble contaminants or, as with annexin II, localized to RPE tissue adhering to drusen, and that additional AMD donors are required to establish the significance of the crystallin observation.
- The paper states that whether any drusen protein is uniquely associated with AMD remains to be determined.
- Evident from the text: the AMD proteomic group was small (five donors), many isolated drusen were from far peripheral locations, and immunocytochemical confirmation covered only ≈16% of identified proteins.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 8 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Among the nine identified immunopositive proteins were albumin and 𝛂 1-antitrypsin, both of which were detected in drusen by LC MS ∕ MS (Table 3) and immunocytochemistry (14).”
What the sources say
- Disputedcites [14] matched to “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease” (2000) sourceExperimental — accuracy not yet measured
Our copy of Mullins et al. (2000) directly contradicts the attributed point: in the Immunohistochemistry section it states that 'Antibodies directed against human serum albumin and haptoglobin bound strongly to the choroidal stroma, but not to hard or soft drusen,' and Table 1 scores Albumin as negative for drusen (figure legend for panel J repeats that labeling was not generally observed with albumin antibodies). Alpha-1-antitrypsin is likewise not presented as an identified drusen component — the same section reports 'Weak and/or inconsistent drusen labeling of antibodies directed against the protease inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin,' and Table 1 lists it as negative with only rare variable reactions. The proteins the paper does identify in all drusen phenotypes are amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X and complement C5/C5b-9 (Abstract; Immunohistochemistry), and the study contains no carboxyethylpyrrole/CEP-adduct work and no LC-MS/MS data. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The multiple, higher mass electrophoretic components containing these proteins suggest the presence of covalent crosslinks, protein modifications that can be caused by reactive lipid and carbohydrate oxidation products (22, 23).”
What the sources say
- Partly supportedcites [22] Friguet, B., Stadtman, E. R. & Szweda, L. I. (1994) J. Biol. Chem. 269, 21639-21643. sourceExperimental — accuracy not yet measured
Friguet et al. (1994) directly support the lipid-oxidation half of what the paired citation is offered for: the Cross-linking of Glu-6-PDH by HNE section (Fig. 1) shows progressive appearance of higher-mass multimeric (dimeric, tetrameric) protein on SDS-gel filtration and SDS-gel electrophoresis after exposure to the lipid peroxidation product HNE, i.e. covalent cross-links, and the Discussion/Abstract state this explicitly. Our copy contains no passage attributing cross-linking to carbohydrate oxidation products (searched: carbohydrate/glycation cross-linking — only lipid peroxidation products HNE and malondialdehyde are discussed), so that half of the claim is not supported by this source; the cross-links shown are also formed in vitro on a heterologous bacterial model enzyme at 5 mM HNE, with the Discussion conceding basal in vivo HNE concentrations are ~3 orders of magnitude lower. The citing authors' own observation of higher-mass electrophoretic components containing TIMP-3 and vitronectin is not something this paper reports. (LLM, conf=0.70)
- Partly supportedcites [23] Elgawish, A., Glomb, M., Friedlander, M. & Monnier, V. M. R. (1996) J. Biol. Chem. 271, 12964-12971. sourceExperimental — accuracy not yet measured
Our copy of Elgawish et al. (1996) supports the carbohydrate-oxidation half of the attributed point: the Introduction (p.1) notes that 'metal-catalyzed glucose autoxidation may be more important than glycation for generation of fluorescent protein adducts and cross-links' and that deoxyosones/glyoxal and 'reactive ketoaldehydes might be responsible for collagen cross-linking', and the Discussion proposes an H2O2- and Amadori-product-driven covalent lysine-lysine cross-link. The lipid-oxidation half is not asserted by this paper: in the Discussion it appears only as an alternative model ('H2O2 ... could catalyze collagen cross-linking, e.g. through lipid peroxidation (44)'), which the authors immediately discount for their system ('Lipid peroxidation, however, is unlikely to be involved since many studies have shown that it is not preventable by catalase'). The paper also reports no electrophoretic high-mass protein components (its cross-linking readouts are tendon breaking time, linked fluorescence, CML, pentosidine), so it does not address the TIMP-3/vitronectin observation itself. (LLM, conf=0.72)
hedgedstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen.”
- Also stated in: § Results · hedged
“Tissue metalloproteinase inhibitor 3 (TIMP3), clusterin, vitronectin and serum albumin appear to be common drusen proteins, detectable in up to 80% of the tissues from the 18 normal donors”
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins.”
- Also stated in: § Results · plain
“Western results (Fig. 3) revealed more frequent CEP immunoreactivity among the AMD samples than in the normal controls. Specifically, nine of the 11 AMD samples were immunopositive whereas only two of the 11 age-matched controls were CEP immunoreactive. Statistically these CEP immunoreactivity results are significantly different between AMD and normal donors (Fischer's test, P value = 0.004 single”
plainstates an associationn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunocytochemical studies have thus far localized ≈ 16% of these proteins in drusen.”
- Also stated in: § Discussion · plain
“To verify drusen localization, immunocytochemical studies are ongoing, and to date 21 of the identified proteins (16%) have been confirmed as drusen components in our laboratories and elsewhere.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
20 more claims
Create a free account to see all 39 claims and to verify the 14 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum albumin is one of the major proteins modified with CEP”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors.”
Reported 65 · recomputed 67.741935
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“About 38% (41 ∕ 107) of the proteins identified from normal donor drusen were also found in drusen from AMD donors”
§ Discussion
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Twenty-one of the 62 proteins detected in drusen from AMD tissue ( ≈ 33%) were not observed in normal donor drusen (Table 3).”
Reported 21 · recomputed 22
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Identification of the gene responsible for Best macular dystrophy
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., et al. (1998) · Nature Genetics · doi:10.1038/915 · Cited by 689
Positional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497
Research works printed but not linked: 3
- Midena E., Deglii Angeli, C., Blarzino, M., Valenti, M. & Segato, T. (1997) Invest. Ophthalmol. Visual Sci.38,469-477.9040480
- Kamei M. & Hollyfield, J. E. (1999) Invest. Ophthalmol. Visual Sci.40,2367-2375.10476804
- Handa, J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T. & Hjelmeland, L. M. (1999) Invest. Ophthalmol. Visual Sci. 40, 775-779.
Cited by
Items 601–700 of 1,000
Rohrer, B., Long, Q., Coughlin, B. A., Renner, B., Huang, Y. J., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Gilkeson, G. S., Thurman, J. M., et al. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_10 · Cited by 35
“These data, combined with the relative lack of immunoglobulins in drusen (which would activate the classical pathway) (Crabb et al. 2002), support the hypothesis that the CAP plays a critical role in driving the pathology of AMD.”
ResultLederman, M., Weiss, A. T., & Chowers, I. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3019 · Cited by 33
Natural products for the treatment of age-related macular degeneration
Wang, D., Chen, Y., Li, J., Wu, E., Tang, T., Singla, R. K., Shen, B., & Zhang, M. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155522 · Cited by 32
Stem cell biology and cell transplantation therapy in the retina
Osakada, F., Hirami, Y., & Takahashi, M. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-297 · Cited by 31
“A major lipid component of the outer segment, docosahexanoate and its oxidized products, as well as carboxyethyl pyrole are more frequently found in the sub-RPE deposits of AMD patients than in controls (Crabb et al., 2002).”
BackgroundParaoan, L., Sharif, U., Carlsson, E., Supharattanasitthi, W., Mahmud, N. M., Kamalden, T. A., Hiscott, P. S., Jackson, M. J., & Grierson, I. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100859 · Cited by 33
Lau, L.-I., Chiou, S., Liu, C. J.-L., Yen, M., & Wei, Y. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7815 · Cited by 34
Identification of Vinculin as a Potential Plasma Marker for Age-Related Macular Degeneration
Kim, H. J., Woo, S. J., Suh, E. J., Ahn, J., Park, J. H., Hong, H. K., Lee, J. E., Ahn, S. J., Hwang, D. D.-J., Kim, K. W., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15168 · Cited by 33
Wei, W., Li, L., Zhang, Y., Geriletu, Yang, J., Zhang, Y., & Xing, Y. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/750634 · Cited by 32
“Proteomic analysis also found numerous proteins which were caused by oxidative damage in drusen [4].”
BackgroundAdamus, G. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.01.005 · Cited by 32
Lu, Z., Lin, V., May, A., Che, B., Xu, X., Shaw, D. H., Su, F., Wang, Z., Du, H., & Shaw, P. X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216808 · Cited by 32
Leung, H. H., Ng, A. L. K., Durand, T., Kawasaki, R., Oger, C., Balas, L., Galano, J., Wong, I. Y., & Lee, J. C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.007 · Cited by 32
Critical Roles of Glutaredoxin in Brain Cells—Implications for Parkinson's Disease
Miller, O. G., & Mieyal, J. J. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7411 · Cited by 31
“The leucine-rich repeat kinase 2 (LRRK2) protein possesses both a kinase mitogen-activated protein kinase kinase kinase domain and Ras GTPase-like domain (21).”
BackgroundFeldman, T. B., Dontsov, A. E., Yakovleva, M. A., & Оstrovsky, М. А. (2022) · Biophysical Reviews · doi:10.1007/s12551-022-00989-9 · Cited by 32
Unfolding the therapeutic potential of chemical chaperones for age-related macular degeneration
Sauer, T. C., Patel, M. M., Chan, C., & Tuo, J. (2008) · Expert Review of Ophthalmology · doi:10.1586/17469899.3.1.29 · Cited by 33
Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products
Kim, Y.-W., Yakubenko, V. P., West, X. Z., Gugiu, G. B., Renganathan, K., Biswas, S., Gao, D., Crabb, J. W., Salomon, R. G., Podrez, E. A., et al. (2015) · Circulation Research · doi:10.1161/circresaha.117.305925 · Cited by 32
Self-citationMechanisms that minimize retinal impact of apolipoprotein E absence
Saadane, A., Petrov, A. M., Mast, N., El‐Darzi, N., Dao, T. V., Alnemri, A. G., Song, Y., Dunaief, J. L., & Pikuleva, I. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m090043 · Cited by 32
New insights and new approaches toward the study of age-related macular degeneration
Bok, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242607899 · Cited by 31
Spacrcan Binding to Hyaluronan and Other Glycosaminoglycans
Chen, Q., Cai, S., Shadrach, K. G., Prestwich, G. D., & Hollyfield, J. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401584200 · Cited by 32
Self-citationMüller cells trophism and pathology as the next therapeutic targets for retinal diseases
Arrigo, A., Cremona, O., Aragona, E., Casoni, F., Consalez, G., Dogru, R. M., Hauck, S. M., Antropoli, A., Bianco, L., Parodi, M. B., et al. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101357 · Cited by 29
“Detailing the different stages of this imaging biomarker imply is association with advanced stages of AMD (Arrigo et al., 2021a,b).”
InfluentialDetection and Biological Activities of Carboxyethylpyrrole Ethanolamine Phospholipids (CEP-EPs)
Wang, H., Guo, J., West, X. Z., Bid, H. K., Liang, L., Hong, L., Jang, G.-F., Zhang, L., Crabb, J. W., Clinical Genomic and Proteomic AMD Study Group, et al. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500216a · Cited by 34
Self-citationIannaccone, A., Hollingsworth, T., Koirala, D., New, D. D., Lenchik, N. I., Beranová-Giorgianni, Š., Gerling, I., Radic, M. Z., & Giorgianni, F. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.12.006 · Cited by 33
“…pathogenesis of AMD has also become far better appreciated, especially since the seminal studies on drusen composition by Hageman et al. (2001). and Crabb et al. (2002). paved the way to the identification of complement factor H (CFH) genetic variants associated to greater odds of having AMD…”
Hongisto, H., Jylhä, A., Nättinen, J. E., Rieck, J., Ilmarinen, T., Veréb, Z., Aapola, U., Beuerman, R. W., Petrovski, G., Uusitalo, H. M. T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06233-9 · Cited by 31
OCTx: Ensembled Deep Learning Model to Detect Retinal Disorders
Paul, D., Tewari, A., Ghosh, S., & Santosh, K. (2020) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms49503.2020.00105 · Cited by 29
“The development of AMD might be eased back or stopped if the genesis of DRUSEN could be controlled [9].”
BackgroundOrganisciak, D. T., WONG, P. W. K., Rapp, C. M., Darrow, R. M., Ziesel, A., Rangarajan, R., & Lang, J. C. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01134.x · Cited by 30
“Crabb et al. (8) and Nakata et al. (9) found that drusen from AMD patients contained a variety of oxidizedlipid protein adducts, present in quantities greater than found in age-matched unaffected individuals.”
InfluentialKim, H. J., Ahn, S. J., Woo, S. J., Hong, H. K., Suh, E. J., Ahn, J., Park, J. H., Ryoo, N.-K., Lee, J. E., Kim, K. W., et al. (2016) · Scientific Reports · doi:10.1038/srep32548 · Cited by 29
Fields, M. A., Bowrey, H. E., Gong, J., Moreira, E. F., Cai, H., & Priore, L. V. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177763 · Cited by 31
Role of the Ubiquitin–Proteasome in Protein Quality Control and Signaling
Shang, F., & Taylor, A. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00010-9 · Cited by 29
Hussain, A. A., Lee, Y., & Marshall, J. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100775 · Cited by 28
Retinal Pigment Epithelium Pigment Granules: Norms, Age Relations and Pathology
Dontsov, A. E., & Оstrovsky, М. А. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073609 · Cited by 30
Sun, J., Huang, P., Liang, J., Li, J., Shen, M., She, X., Feng, Y., Luo, X., Liu, T., & Sun, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.502 · Cited by 29
“subretinal pigment epithelial deposits – drusen, which is composed of a range of proteins and lipids.(7) Increasing evidences support that amyloid-beta (Aβ), one of the”
BackgroundInnate Immunity in Age-Related Macular Degeneration
Zhang, Y., & Wong, W. T. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_5 · Cited by 28
Dabbs, R. A., Wyatt, A. R., Yerbury, J. J., Ecroyd, H. W., & Wilson, M. R. (2011) · Topics in current chemistry · doi:10.1007/128_2011_262 · Cited by 29
“6 μg/ml (CSF) 2-15 mg/ml (seminal plasma) Holdase-type chaperone activity similar to the small heat shock proteins * Associated with extracellular deposits tested including age related macular degeneration, Creutzfeldt-Jakob disease, atherosclerosis, Alzheimer’s disease * Upregulated in experimental models of stress *…”
BackgroundMethodOcular Proteomics with Emphasis on Two-Dimensional Gel Electrophoresis and Mass Spectrometry
Mandal, N., Heegaard, S., Prause, J. U., Honoré, B., & Vorum, H. (2009) · Biological Procedures Online · doi:10.1007/s12575-009-9019-7 · Cited by 29
“An et al. (129) used SILAC and LC-ESI-MS/MS to examine the differential protein secretion of RPE cells in relation to drusen and pathological changes of AMD.”
BackgroundInfluentialSparrow, J. R., Dowling, J. E., & Bok, D. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13214 · Cited by 30
Medoro, A., Davinelli, S., Scuderi, L., Scuderi, G., Scapagnini, G., & Fragiotta, S. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s516946 · Cited by 32
Bowrey, H. E., Anderson, D. M., Pallitto, P. M., Gutierrez, D. B., Fan, J., Crouch, R. K., Schey, K. L., & Ablonczy, Z. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500103 · Cited by 31
Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
Mohebnasab, M., Eriksson, O., Persson, B., Sandholm, K., Mohlin, C., Huber-Lang, M. S., Keating, B. J., Ekdahl, K. N., & Nilsson, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02539 · Cited by 28
A vicious cycle of bisretinoid formation and oxidation relevant to recessive Stargardt disease
Zhao, J., Kim, H. J., Ueda, K., Zhang, K., Montenegro, D., Dunaief, J. L., & Sparrow, J. R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100259 · Cited by 27
“These dicarbonyls modify proteins and have been described in sub-RPE drusen (46, 47).”
BackgroundResolution of Inflammation in Retinal Disorders: Briefly the State
Trotta, M. C., Gesualdo, C., Petrillo, F., Lepre, C. C., Corte, A. D., Cavasso, G., Maggiore, G., Hermenean, A. O., Simonelli, F., D’Amico, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094501 · Cited by 27
Charvet, C. D., Saadane, A., Wang, M., Salomon, R. G., Brunengraber, H., Turko, I. V., & Pikuleva, I. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498832 · Cited by 30
Self-citationSaeed, A. M., Duffort, S., Ivanov, D., Wang, H., Laird, J. M., Salomon, R. G., Cruz‐Guilloty, F., & Perez, V. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106421 · Cited by 29
“Given that the retina is highly abundant in CEP, in a recent report we sought to determine if CEP can directly induce expression of these two inflammatory cytokines in macrophages [11,13,21,22].”
BackgroundSelf-citationAn eye on the future of inflammasomes and drug development in AMD
Campbell, M., & Doyle, S. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1050-0 · Cited by 29
“In fact, CEP is highly abundant in AMD, decorating drusen proteins and retinal cell membranes [20, 43].”
Early biosignature of oxidative stress in the retinal pigment epithelium
Arnouk, H., Lee, H., Zhang, R., Chung, H., Hunt, R. C., & Jahng, W. J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.11.004 · Cited by 27
“Recently, pioneering proteomic profiling studies revealed the protein expressions in human RPE [21], drusen [22] and lipofuscin [23].”
BackgroundTargeting Inflammation in Emerging Therapies for Genetic Retinal Disease
viringipurampeer, I. A., Bashar, E., Gregory, C. Y., Moritz, O. L., & Gregory-Evans, K. (2013) · International Journal of Inflammation · doi:10.1155/2013/581751 · Cited by 30
“For instance, other studies have highlighted the appearance of oxidative protein modifications within AMD drusen including cross-linked species of tissue metalloproteinase inhibitor 3, vitronectin, and carboxyethyl pyrrole protein adducts suggesting oxidative stress as an etiological factor in AMD drusen formation [20…”
BackgroundLipid metabolites in the pathogenesis and treatment of neovascular eye disease
Stahl, A., Krohne, T. U., Sapieha, P. S., Chen, J., Hellström, A., Chew, E. Y., Holz, F. G., & Smith, L. E. H. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.194241 · Cited by 28
“ALEs are also found in RPE-derived lipofuscin isolated from human donor eyes(31) as well as in drusen and Bruch’s membrane of AMD patients.(32) Photoreceptor cells cope with damage by continuous shedding and renewal of their PUFA-rich outer (1)Department of Ophthalmology,”
BackgroundIwanishi, H., Fujita, N., Tomoyose, K., Okada, Y., Yamanaka, O., Flanders, K. C., & Saika, S. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.30 · Cited by 28
C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function
Molins, B., Pascual, A., Méndez, Llorenç, V., Zarranz‐Ventura, J., Mesquida, M., Adán, A., & Martorell, J. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00057.2016 · Cited by 29
“Components of the complement system and inflammatory proteins are present in drusen, providing further evidence that local inflammation and immunemediated processes play a central role in AMD pathogenesis (5, 15).”
BackgroundRodríguez-Menéndez, S., Fernández, B., García, M., Álvarez, L., Fernández‐Sánchez, M. L., Sanz‐Medel, A., Coca‐Prados, M., Pereiro, R., & González‐Iglesias, H. (2017) · Talanta · doi:10.1016/j.talanta.2017.09.024 · Cited by 27
Defence against oxidative damage
Cruz‐Guilloty, F., & Perez, V. L. (2011) · Nature · doi:10.1038/478042a · Cited by 27
Molecular Insight into the Regulation of Vimentin by Cysteine Modifications and Zinc Binding
Mónico, A., Guzman‐Caldentey, J., Pajares, M. A., Martín‐Santamaría, S., & Pérez‐Sala, D. (2021) · Antioxidants · doi:10.3390/antiox10071039 · Cited by 27
“In addition, zinc is able to induce aggregation of vimentin and other proteins [45,103], which could contribute to pathologies associated with extracellular accumulations of vimentin and zinc, such as the pathological deposits that develop in diseases such as age-related macular degeneration [104].”
BackgroundDNA Damage/Repair and Polymorphism of the hOGG1 Gene in Lymphocytes of AMD Patients
Woźniak, K., Szaflik, J. P., Zaraś, M., Skłodowska, A., Janik-Papis, K., Popławski, T., Błasiak, J., & Szaflik, J. (2009) · BioMed Research International · doi:10.1155/2009/827562 · Cited by 30
“observation that large drusen, which are deposited under the RPE in patients with macular degeneration, consist of insoluble aggregates of oxidized lipids and proteins derived from the photochemical reactions of visual transduction [14, 15].”
BackgroundPaik, D. C., Saito, L. Y., Sugirtharaj, D. D., & Holmes, J. W. (2006) · Connective Tissue Research · doi:10.1080/03008200600721569 · Cited by 27
Wu, Z., Hasan, A., Liu, T., Teller, D. C., & Crabb, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401960200 · Cited by 27
Self-citationJournal of Research and Education in Indian Medicine
(2026) · Journal of Research and Education in Indian Medicine · doi:10.5455/jreim · Cited by 27
“Websites of concerned agencies were also scrutinized.[25-39]”
Pilot Application of iTRAQ to the Retinal Disease Macular Telangiectasia
Len, A. C. L., Powner, M. B., Zhu, L., Hageman, G. S., Song, X., Fruttiger, M., & Gillies, M. C. (2011) · Journal of Proteome Research · doi:10.1021/pr200889t · Cited by 26
Long-Chain Polyunsaturated Fatty Acids and Age-Related Macular Degeneration
Skowronska‐Krawczyk, D., & Chao, D. L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-27378-1_7 · Cited by 28
Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes
Hu, J. G., Pauer, G. J. T., Hagstrom, S. A., Bok, D., DeBenedictis, M. J., Bonilha, V. L., Hollyfield, J. G., & Radu, R. A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101787 · Cited by 30
Self-citationImmunological Aspects of Age-Related Macular Degeneration
Allingham, M. J., Loksztejn, A., Cousins, S. W., & Mettu, P. S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_6 · Cited by 26
The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing
Gross, C., Guérin, L.-P., Socol, B. G., Germain, L., & Guérin, S. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713182 · Cited by 29
Photo-products of retinal pigment epithelial bisretinoids react with cellular thiols.
Yoon, K. D., Yamamoto, K., Zhou, J., & Sparrow, J. R. (2011) · PubMed Central · Cited by 27
Lynn, S. A., Ward, G., Keeling, E., Scott, J. A., Cree, A. J., Johnston, D. A., Page, A. M., Cuan‐Urquizo, E., Bhaskar, A., Grossel, M. C., et al. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.06.003 · Cited by 26
Sheibani, N., Farnoodian, M., & Sorenson, C. M. (2018) · Journal of Ophthalmic and Vision Research · doi:10.4103/jovr.jovr_67_18 · Cited by 27
“[77‐79] AGEs are found in drusen bodies, which are considered early clinical signs of AMD.[80] They can also contribute to the formation of CNV.”
BackgroundHellinen, L., Sato, K., Reinisalo, M., Kidron, H., Rilla, K. J., Tachikawa, M., Uchida, Y., Terasaki, T., & Urtti, A. O. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27328 · Cited by 28
Growth-related effects of oxidant-induced stress on cultured RPE and choroidal endothelial cells
Eichler, W., Reiche, A., Yafai, Y., Lange, J., & Wiedemann, P. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.06.017 · Cited by 27
Guymer, R. H., & Robman, L. D. (2007) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01392.x · Cited by 29
Wang, Z., Paik, D. C., Priore, L. V. D., Scholar, R. L. B. I., & Gaillard, E. R. (2005) · Current Eye Research · doi:10.1080/02713680590968259 · Cited by 26
COMPLEMENT FACTOR H VARIANT INCREASES THE RISK FOR EARLY AGE-RELATED MACULAR DEGENERATION
LIN, J.-M., TSAI, Y.-Y., Wan, L., Lin, H.-J., Tsai, Y., Lee, C. C., Tsai, C. H., Tsai, F. J., & Tseng, S.-H. (2008) · Retina · doi:10.1097/iae.0b013e318184661d · Cited by 28
Sallo, F. B., Bereczki, E., Csont, T., Luthert, P. J., Munro, P., Ferdinandy, P., Sántha, M., & Lengyel, I. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.03.006 · Cited by 25
“This might be related to the presence of biglycan in drusen in human (Crabb et al., 2002).”
BackgroundStem Cell Treatment for Age-Related Macular Degeneration: the Challenges
Singh, M. S., & MacLaren, R. E. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24426 · Cited by 25
Complement inhibitors for age-related macular degeneration
Williams, M. A., McKay, G. J., & Chakravarthy, U. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009300.pub2 · Cited by 25
Lutein and Factor D: Two intriguing players in the field of age-related macular degeneration
Tian, Y., Kijlstra, A., Webers, C. A. B., & Berendschot, T. T. J. M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.01.019 · Cited by 26
The link between morphology and complement in ocular disease
Mohlin, C., Sandholm, K., Ekdahl, K. N., & Nilsson, B. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.028 · Cited by 31
Chiang, T. T.-K., Keenan, T. D. L., Agrón, E., Liao, J., Klein, B., Chew, E. Y., Cukras, C. A., & Wong, W. T. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.6.59 · Cited by 27
Romero‐Vázquez, S., Adán, A., Figueras‐Roca, M., Llorenç, V., SLEVIN, M. A., Vilahur, G., Badimón, L., Dick, A. D., & Molins, B. (2020) · Aging · doi:10.18632/aging.103655 · Cited by 26
“Histochemical and proteomic analysis of ocular drusen, the hallmark deposits of AMD, have shown that these deposits contain inflammatory proteins and complement components that mediate local inflammation [9, 10].”
Chen, J., Sun, J., Hu, Y., Wan, X., Wang, Y., Gao, M., Liang, J., Liu, T., & Sun, X. (2021) · The FASEB Journal · doi:10.1096/fj.202000645rr · Cited by 29
Application of proteomic technology in eye research: a mini review
Lam, T. C., Chun, R. K. M., Li, K. K., & To, C. H. (2007) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2007.00194.x · Cited by 27
“Others have studied the drusen in the ARM retina, using liquid chromatography tandem MS for protein identification and modification.(121,146) The data strongly support a key role of oxidative protein modifications in the drusen formation and the pathogenesis of ARM.”
MethodPreliminary quantitative proteomic characterization of glaucomatous rat retinal ganglion cells
Crabb, J. W., Yuan, X., Dvoriantchikova, G., Ivanov, D., Crabb, J. S., & Shestopalov, V. I. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.04.004 · Cited by 25
“While previous qualitative proteomic studies have provided insights to a variety of ocular disorders (Crabb et al., 2002; Ng et al., 2008; Zhan et al., 2008) including glaucoma (Bhattacharya et al.”
Self-citationLanda, G., Rosen, R. B., Patel, A. P., Lima, V. C., Tai, K. W., Perez, V. R., Aizman, A., & Garcia, P. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0109 · Cited by 26
“25 The ability of Copaxone to induce reduction of drusen is probably dependent upon the immunohistochemical composition of a particular druse, which may explain why different drusen patterns in different patients demonstrate different responses to Copaxone treatment.”
Prohibitin as the Molecular Binding Switch in the Retinal Pigment Epithelium
Sripathi, S. R., Sylvester, O., He, W., Moser, T. H., Um, J.-Y., Lamoke, F., Ramakrishna, W., Bernstein, P. S., Bartoli, M., & Jahng, W. J. (2015) · The Protein Journal · doi:10.1007/s10930-015-9641-y · Cited by 24
“Later, AMD progresses into two distinct advanced forms as nonneovascular (atrophic, dry) and neovascular (exudative, wet) phenotypes [26, 27].”
The cGAS–STING Pathway in Diabetic Retinopathy and age-related Macular Degeneration
Hu, B., Ma, J., & Duerfeldt, A. S. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0301 · Cited by 24
Geographic atrophy: pathophysiology and current therapeutic strategies
Rajanala, K., Dotiwala, F., & Upadhyay, A. K. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1327883 · Cited by 30
Chen, X., Zhang, W., Laird, J. M., Hazen, S. L., & Salomon, R. G. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700598-jlr200 · Cited by 28
“of individuals with age-related macular degeneration (37, 38).”
BackgroundSelf-citationThe Clinical Application of Ozonetherapy
Bocci, V. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9234-2_9 · Cited by 31
Noninvasive Imaging of Mitochondrial Dysfunction in Dry Age-Related Macular Degeneration
Field, M. G., Comer, G. M., Kawaji, T., Petty, H. R., & Elner, V. M. (2012) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20120712-02 · Cited by 24
Comparative Proteomic Analysis of Two Uveitis Models in Lewis Rats
Pepple, K. L., Rotkis, L., Wilson, L., Sandt, A., & Gelder, R. N. V. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17524 · Cited by 25
Mutant Fibulin-3 Causes Proteoglycan Accumulation and Impaired Diffusion Across Bruch's Membrane
Zayas‐Santiago, A., Cross, S. D., Stanton, J. B., Marmorstein, A. D., & Marmorstein, L. Y. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21720 · Cited by 24
“33 These mice recapitulate the important histopathology of ML/DHRD.”
BackgroundAnnexin A5 Directly Interacts with Amyloidogenic Proteins and Reduces Their Toxicity
Bedrood, S., Jayasinghe, S. A., Sieburth, D., Chen, M., Erbel, S., Butler, P. C., Langen, R., & Ritzel, R. A. (2009) · Biochemistry · doi:10.1021/bi900608m · Cited by 27
“of subjects with age-related macular degeneration contain annexin A5 (33).”
BackgroundOxidative Stress and the Ubiquitin Proteolytic System in Age-Related Macular Degeneration
Plafker, S. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_51 · Cited by 24
“Importantly, CEP is adducted to proteins in drusen deposits (Crabb et al. 2002) and CEP-adducted protein levels are elevated in the plasma of AMD patients (Gu et al.”
BackgroundA High Fat “Western‐style” Diet Induces AMD‐Like Features in Wildtype Mice
Keeling, E., Lynn, S. A., Koh, Y. M., Scott, J. A., Kendall, A., Gatherer, M., Page, A. M., Cagampang, F. R. A., Lotery, A. J., & Ratnayaka, J. A. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100823 · Cited by 24
Granzyme B as a therapeutic target: an update in 2022
Aubert, A., Lane, M. D., Jung, K., & Granville, D. J. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2161890 · Cited by 24
“deposits of lipids) between the retinal pigment epithelium (RPE) and the Bruch’s membrane of the retina [68,69].”
BackgroundMicrophysiological systems for human aging research
Park, S., Laskow, T. C., Chen, J., Guha, P., Dawn, B., & Kim, D. (2024) · Aging Cell · doi:10.1111/acel.14070 · Cited by 23
“…of protein oxidation and misfolding can cause proteolysis-resistant aggregates, as well as lipid-protein aggregates associated with dysregulation and dysfunction of the central nervous sys-tem and the pathogenesis of neurodegenerative diseases (NDs) (Caughey & Lansbury, 2003; Crabb et al., 2002).”
BackgroundNita, M., & Grzybowski, A. E. (2020) · EXCLI journal · doi:10.17179/excli2020-2915 · Cited by 25
“Laboratory studies confirmed AGEs deposits in soft drusen (Crabb et al., 2002) and in Bruch’s membrane (Tian et al., 2005).”
BackgroundLiu, Z., Qin, T., Zhou, J., Taylor, A., Sparrow, J. R., & Shang, F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_31 · Cited by 25
Induction of vitronectin and integrin alphav in the retina after optic nerve injury.
Wang, A. G., Yen, M.-Y., Hsu, W., & Fann, M. (2006) · PubMed · Cited by 23
Accumulation of D ‐ β ‐Aspartic Acid‐Containing Proteins in Age‐Related Ocular Diseases
Kaji, Y., Oshika, T., Takazawa, Y., Fukayama, M., & Fujii, N. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900329 · Cited by 25
Mass spectrometry in aging research
Schöneich, C. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20035 · Cited by 26
Exploring the cross talk between ER stress and inflammation in age-related macular degeneration
Kheitan, S., Minuchehr, Z., & Soheili, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181667 · Cited by 22
What Does Genetics Tell Us About Age-Related Macular Degeneration?
Graßmann, F., Ach, T., Brandl, C., Heid, I. M., & Weber, B. H. F. (2015) · Annual Review of Vision Science · doi:10.1146/annurev-vision-082114-035609 · Cited by 24
Thrombospondin-1 and Pathogenesis of Age-Related Macular Degeneration
Housset, M., & Sennlaub, F. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0023 · Cited by 22
“They are composed of lipids, glycoproteins, 43 and contain numerous degenerating organelles, 44 suggesting that they are, at least in part, composed of cell debris that failed to be phagocytized by local cells or macrophages.”
Complement Factor H Deficiency Results in Decreased Neuroretinal Expression of Cd59a in Aged Mice
Faber, C., Williams, J. A. E., Juel, H. B., Greenwood, J., Nissen, M. H., & Moss, S. E. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10385 · Cited by 23
“Unlike MAC and the negative regulators MCP/CD46, CFH, vitronectin, and clusterin, CD59 is one of a few complement-related molecules, which, to the best of our knowledge, has not been identified in drusen.(3,4,9) While negative results have to be interpreted with caution, it does support our hypothesis that down-regula…”
BackgroundResult
Metadata
- Authors
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 23
- Pages
- 14682-14687
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137479
- OpenAlex
- W2136501493
- Semantic Scholar
- 56777252bd03c9f9e59663891e03c8a458996b5f
- Cited by
- 1,208
- References
- 39
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 35 · 2023: 39 · 2022: 52 · 2021: 56 · 2020: 49 · 2019: 34 · 2018: 65 · 2017: 62 · 2016: 44 · 2015: 56 · 2014: 73 · 2013: 57 · 2012: 69
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation Fighting Blindness
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health (5r01ey002362-23, EY06603)
- National Eye Institute (R56EY014240, EY014239, EY06603, EY 014240, F32EY006603, R01EY006603, R01EY014239, EY 02362, R01EY014240)
- National Institute of General Medical Sciences (R01GM021249, GM 21249)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- drusen, age-related macular degeneration, Bruch's membrane, retinal pigment epithelium, protein oxidation, carboxymethyllysine, vitronectin, clusterin, serum albumin, crystallins, drusen formation, AMD pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Aging, Choroid, Enzymes, Eye, Eye Proteins, Humans, Macular Degeneration, Middle Aged, Reference Values, Retina, Optic Disk Drusen, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.